Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
8,537
datasets available to search
ShareScore release 0.9.0
Dataset results
8,537 results for “Openness”
An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.
ClinicalTrials.gov study NCT01582061. IPD Sharing: UNDECIDED. Countries: 11. Publications: 1.
Open Label Study of Long Term Safety Evaluation of Alirocumab
ClinicalTrials.gov study NCT01954394. IPD Sharing: Not stated. Countries: 24. Publications: 3.
Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study
ClinicalTrials.gov study NCT04233372. IPD Sharing: UNDECIDED. Countries: 2. Publications: 1.
Open-Label Extension of Study R727-CL-1003 (NCT01266876) to Evaluate the Long-Term Safety and Efficacy of Alirocumab (REGN727) in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)
ClinicalTrials.gov study NCT01576484. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Open Label Extension In Cancer Patients
ClinicalTrials.gov study NCT00830180. IPD Sharing: YES. Countries: 10. Publications: 1.
Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants
ClinicalTrials.gov study NCT04520451. IPD Sharing: YES. Countries: 5. Publications: 1.
A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofus
ClinicalTrials.gov study NCT01907087. IPD Sharing: Not stated. Countries: 4. Publications: 4.
Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02453282. IPD Sharing: YES. Countries: 17. Publications: 2.
An Open-label Safety, Tolerability and Dose-Range Finding Study of Multiple Doses of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy
ClinicalTrials.gov study NCT01703988. IPD Sharing: YES. Countries: 1. Publications: 1.
An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease
ClinicalTrials.gov study NCT00632736. IPD Sharing: YES. Countries: 9. Publications: 1.
A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
ClinicalTrials.gov study NCT02842242. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome
ClinicalTrials.gov study NCT04279314. IPD Sharing: NO. Countries: 1. Publications: 2.
Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
ClinicalTrials.gov study NCT01118962. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01724346. IPD Sharing: YES. Countries: 16. Publications: 5.
A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis
ClinicalTrials.gov study NCT01216072. IPD Sharing: Not stated. Countries: 3. Publications: 4.
Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG)
ClinicalTrials.gov study NCT03651336. IPD Sharing: NO. Countries: 1. Publications: 1.
Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
ClinicalTrials.gov study NCT00662038. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
ClinicalTrials.gov study NCT02061683. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)
ClinicalTrials.gov study NCT05025241. IPD Sharing: NO. Countries: 1. Publications: 1.
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
ClinicalTrials.gov study NCT03084471. IPD Sharing: YES. Countries: 8. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.